Proteomic Studies on the Development of the Central Nervous System and Beyond

被引:6
作者
Zhang, Chenggang [1 ]
机构
[1] Beijing Inst Radiat Med, State Key Lab Prote, Beijing 100850, Peoples R China
基金
中国国家自然科学基金;
关键词
Proteomics; Neuroproteomics; Development; Central nervous system; EMBRYONIC CEREBROSPINAL-FLUID; ALZHEIMERS-DISEASE BRAIN; PLASMA-MEMBRANE PROTEINS; PROJECT PILOT PHASE; NEURAL STEM-CELLS; HUMAN FETAL-BRAIN; MOUSE-BRAIN; REDOX PROTEOMICS; CSF BIOMARKERS; HIPPOCAMPAL PROTEOME;
D O I
10.1007/s11064-010-0218-z
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Neuroproteomics has become a 'symbol' or even a 'sign' for neuroscientists in the post-genomic era. During the last several decades, a number of proteomic approaches have been used widely to decipher the complexity of the brain, including the study of embryonic stages of human or non-human animal brain development. The use of proteomic techniques has allowed for great scientific advancements, including the quantitative analysis of proteomic data using 2D-DIGE, ICAT and iTRAQ. In addition, proteomic studies of the brain have expanded into fields such as subproteomics, synaptoproteomics, neural plasma membrane proteomics and even mitochondrial proteomics. The rapid progress that has been made in this field will not only increase the knowledge based on the neuroproteomics of the developing brain but also help to increase the understanding of human neurological diseases. This paper will focus on proteomic studies in the central nervous system and especially those conducted on the development of the brain in order to summarize the advances in this rapidly developing field.
引用
收藏
页码:1487 / 1500
页数:14
相关论文
共 111 条
  • [1] Proteomic identification of differentially expressed genes in mouse neural stem cells and neurons differentiated from embryonic stem cells in vitro
    Akama, Kuniko
    Tatsuno, Ryosuke
    Otsu, Masahiro
    Horikoshi, Tomoe
    Nakayama, Takashi
    Nakamura, Megumi
    Toda, Tosifusa
    Inoue, Nobuo
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2008, 1784 (05): : 773 - 782
  • [2] Andrade EC, 2007, CURR OPIN MOL THER, V9, P270
  • [3] Bai Fengju, 2007, V43, P77, DOI 10.1007/978-1-4020-5943-8_6
  • [4] The audacity of proteomics: a chance to overcome current challenges in schizophrenia research
    Baloyianni, Nicoletta
    Tsangaris, George Th
    [J]. EXPERT REVIEW OF PROTEOMICS, 2009, 6 (06) : 661 - 674
  • [5] Growth hormone action in the developing neural retina: A proteomic analysis
    Baudet, Marie-Laure
    Hassanali, Zahra
    Sawicki, Grzegorz
    List, Edward O.
    Kopchick, John J.
    Harvey, Steve
    [J]. PROTEOMICS, 2008, 8 (02) : 389 - 401
  • [6] Neuroproteomics: understanding the molecular organization and complexity of the brain
    Bayes, Alex
    Grant, Seth G. N.
    [J]. NATURE REVIEWS NEUROSCIENCE, 2009, 10 (09) : 635 - 646
  • [7] Neuroproteomics - the tasks lying ahead
    Becker, Michael
    Schindler, Jens
    Nothwang, Hans Gerd
    [J]. ELECTROPHORESIS, 2006, 27 (13) : 2819 - 2829
  • [8] Preliminary analysis of the mouse cerebellum proteome
    Beranova-Giorgianni, S
    Pabst, MJ
    Russell, TM
    Giorgianni, F
    Goldowitz, D
    Desiderio, DM
    [J]. MOLECULAR BRAIN RESEARCH, 2002, 98 (1-2): : 135 - 140
  • [9] Investigating protein isoforms via proteomics: A feasibility study
    Blakeley, Paul
    Siepen, Jennifer A.
    Lawless, Craig
    Hubbard, Simon J.
    [J]. PROTEOMICS, 2010, 10 (06) : 1127 - 1140
  • [10] CSF biomarkers for Alzheimer's disease: use in early diagnosis and evaluation of drug treatment
    Blennow, K
    [J]. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2005, 5 (05) : 661 - 672